Revenue: The sum of all revenue fields included for a company's operating activities.
Carisma Therapeutics Inc. (CARM) had Revenue of $19.63M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$19.63M |
$-60.48M |
|
-- |
|
$19.63M |
|
$81.81M |
|
$-62.18M |
|
$1.70M |
|
$-60.48M |
|
$-60.48M |
|
$-60.48M |
|
$-60.48M |
|
$-60.48M |
|
$-60.48M |
|
$-62.18M |
|
$-58.83M |
|
41.46M |
|
41.46M |
|
$-1.46 |
|
$-1.46 |
|
| Balance Sheet Financials | |
$23.82M |
|
$4.38M |
|
$6.63M |
|
$30.46M |
|
$16.05M |
|
$0.02M |
|
$42.31M |
|
$58.37M |
|
$-27.91M |
|
$-27.91M |
|
$-27.91M |
|
41.75M |
|
| Cash Flow Statement Financials | |
$-59.92M |
|
$-0.12M |
|
$0.34M |
|
$77.61M |
|
$17.91M |
|
$-59.70M |
|
$3.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.48 |
|
-- |
|
-- |
|
-0.00 |
|
-0.03 |
|
100.00% |
|
-316.72% |
|
-316.72% |
|
-299.64% |
|
-308.05% |
|
-308.05% |
|
$-60.04M |
|
-- |
|
-- |
|
-- |
|
0.64 |
|
-- |
|
-- |
|
-- |
|
216.69% |
|
216.69% |
|
-198.56% |
|
216.85% |
|
$-0.67 |
|
$-1.45 |
|
$-1.45 |
|